Thermo Fisher Scientific has moved to acquire viral vector developer and manufacturer Brammer Bio for $1.7 billion in cash.
Bayer is teaming up with a Swedish digital health startup focused on boosting patient compliance with an internet-connected pillbox.
An FDA panel voted against clearance for Neuronix's transcranial magnetic stimulation device, which targets the brain’s memory and learning centers.
A toilet seat monitoring system aims to spot the signs of heart failure in the privacy of the home, with the goal of lowering hospital readmissions.
The FDA approved a heart implant from Impulse Dynamics for patients who aren’t able to use a pacemaker or standard therapies.
Sherlock Biosciences is launching with $35 million and a two-pronged approach to improving the current state of diagnostics.
Fresenius’ new global medical office will head up its work in clinical science and coordinate the company’s global network of clinics.
The FDA’s warning letters to breast implant manufacturers come during newly galvanized agency probes into the long-term safety of silicone implants.
A new assay that combines Illumina's ultradeep sequencing with Grail's machine-learning algorithm could detect multiple targetable cancer mutations.
After a limited launch of its automated glucose monitoring system, OptiScan has raised $20 million for a broader rollout.
